tyrosine kinase inhibitor

You have access
Chronic Myelocytic Leukemia – Part I: History, Clinical Presentation, and Molecular Biology
Tim R Randolph

American Society for Clinical Laboratory Science January 2005, 18 (1) 38-48; DOI: https://doi.org/10.29074/ascls.18.1.38
You have access
Chronic Myelocytic Leukemia – Part II: Approaches to and Molecular Monitoring of Therapy
Tim R Randolph

American Society for Clinical Laboratory Science January 2005, 18 (1) 49-56; DOI: https://doi.org/10.29074/ascls.18.1.49

Main menu